Two Sigma Securities, LLC Pro Qr Therapeutics N.V. Transaction History

Two Sigma Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.39 $18,582 - $26,916	-11,262 Reduced 47.45%	12,471 $20,000
Q1 2024 May 15, 2024	BUY	$1.89 - $2.85 $24,751 - $37,323	13,096 Added 123.12%	23,733 $54,000
Q4 2023 Feb 14, 2024	BUY	$1.15 - $2.21 $12,232 - $23,507	10,637 New	10,637 $21,000
Q1 2023 May 15, 2023	BUY	$1.99 - $3.66 $37,891 - $69,690	19,041 New	19,041 $40,000
Q2 2022 Aug 15, 2022	BUY	$0.56 - $1.0 $7,772 - $13,880	13,880 Added 99.56%	27,821 $22,000
Q1 2022 May 16, 2022	BUY	$0.9 - $8.39 $12,546 - $116,964	13,941 New	13,941 $13,000

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $188M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.